Impact of sorafenib dosing on outcome from the European patient subset of the GIDEON study

dc.contributor.author	Turnes Vázquez, Juan
dc.date.accessioned	2017-06-07T07:24:53Z
dc.date.available	2017-06-07T07:24:53Z
dc.date.issued	2015
dc.identifier.issn	1479-6694
dc.identifier.uri	http://hdl.handle.net/20.500.11940/6153
dc.language.iso	eng
dc.title	Impact of sorafenib dosing on outcome from the European patient subset of the GIDEON study
dc.type	Artigo	es
dc.authorsophos	Daniele, B.
dc.authorsophos	Croitoru, A.
dc.authorsophos	Papandreou, C.
dc.authorsophos	Bronowicki, J. P.
dc.authorsophos	Mathurin, P.
dc.authorsophos	Serejo, F.
dc.authorsophos	Stål, P.
dc.authorsophos	Turnes, J.
dc.authorsophos	Ratziu, V.
dc.authorsophos	Bodoky, G.
dc.identifier.doi	10.2217/fon.15.163
dc.identifier.isi	362035600009
dc.identifier.pmid	26158398
dc.identifier.sophos	18404
dc.issue.number	18
dc.journal.title	Future Oncology
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Pontevedra e O Salnés - Complexo Hospitalario Universitario de Pontevedra::Dixestivo
dc.page.initial	2553
dc.page.final	2562
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	11

Files in this item

Files	Size	Format	View
There are no files associated with this item.